Harvard Catalyst brings together the intellectual force, technologies, and clinical expertise of Harvard University and its affiliates and partners to reduce the burden of human illness.

Harvard Catalyst | The Harvard Clinical and Translational Science Center is dedicated to improving human health by enabling collaboration and providing tools, training and technologies to clinical and translational investigators. Founded in May 2008, Harvard Catalyst is a shared enterprise of Harvard University, its ten schools and its eighteen Academic Healthcare Centers (AHC), as well as the Boston College School of Nursing, MIT, Harvard Pilgrim Health Care, and numerous community partners.

Harvard Catalyst is a member of the NIH-funded Clinical and Translational Science Award (CTSA) Consortium, and shares tools, technologies, and best practices with other consortium members locally (i.e., Boston University, Tufts University, University of Massachusetts Medical School) and nationally.

Harvard Catalyst resources are available to all Harvard faculty, regardless of their institutional affiliation or academic degree.

Participating Institutions

• Beth Israel Deaconess Medical Center
• Brigham and Women's Hospital
• Broad Institute
• Cambridge Health Alliance
• Children's Hospital Boston
• Dana-Farber Cancer Institute
• Forsyth Institute
• Harvard Pilgrim Health Care
• Hebrew SeniorLife
• Immune Disease Institute
• Joslin Diabetes Center
• Judge Baker Children's Center
• Massachusetts Eye & Ear Infirmary
• Massachusetts General Hospital
• McLean Hospital
• Mount Auburn Hospital
• Schepens Eye Research Institute
• Spaulding Rehabilitation Hospital
• Veterans Affairs Boston Healthcare System